Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07135284Recruiting
Testing the LibAirty System for Bronchiectasis at Home
This trial tests the LibAirty system, a device that helps clear mucus from your lungs, in people with bronchiectasis. Participants use the device at home to see how well it works in daily life.
Birmingham, AlabamaAges 21 years+ - NCT07133477Recruiting
Fish oil for skin health
This study tests whether taking fish oil concentrate can improve skin function in adults who have sensitive, redness-prone skin. If you're between 35 and 65 and have skin that easily gets dry or red, this might be a good fit.
CardiffAges 35–65 - NCT07130604RecruitingPhase 3
Testing a new pill for moderate to severe plaque psoriasis
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
Beijing, Beijing MunicipalityAges 18–70 - NCT07129382RecruitingPhase 1/Phase 2
Study of CS32582 for moderate to severe plaque psoriasis
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
Beijing, Beijing MunicipalityAges 18–70 - NCT07132255Enrolling by invitation
Study of remote robot-assisted heart stent placement
This trial tests whether a doctor can use a robot to place a heart stent while being in a different location. It is designed for people who need a stent to open a blocked heart artery.
Jimsar, Xinjiang Uygur Autonomous RegionAges 18–80 - NCT07133308RecruitingPhase 3
Study of deuruxolitinib for teens with severe alopecia areata
This study tests an investigational oral medication (deuruxolitinib) for adolescents with severe alopecia areata (hair loss). It aims to see if it can help hair regrow safely.
Birmingham, AlabamaAges 12–17 - NCT07134465Enrolling by invitationPhase 1
Drug interaction study of HSK31858 and itraconazole
This study checks if itraconazole changes how the body processes HSK31858. Healthy volunteers are needed to help understand the safety and drug levels.
ShanghaiAges 18–45 - NCT07126912Recruiting
Alcarisa filler for mid-face volume restoration
This trial tests a new hyaluronic acid filler called Alcarisa to restore volume in the mid-face (cheek area). It may be a good option if you are looking for a non-surgical way to treat moderate to significant cheek volume loss.
Tehran, Tehran ProvinceAges 30–65 - NCT06962371Recruiting
A study testing a new device during TAVR heart valve replacement
This trial is testing a new device called POINT-GUARD that is used during TAVR (a procedure to replace a heart valve). It aims to see if the device can safely catch any debris or particles that might travel to the brain during the procedure.
Clayton, VictoriaAges 18 years+ - NCT07133516Recruiting
AI heart ultrasound study for adults ages 18-80
This study uses artificial intelligence to help evaluate heart ultrasounds. It is testing whether AI can accurately measure heart function in adults with various heart conditions, such as coronary disease, valve problems, high blood pressure, atrial fibrillation, heart failure, or cardiomyopathy.
Huainan, AnhuiAges 18–80 - NCT07134361Recruiting
Ultrasound study for carpal tunnel syndrome
This study uses hand ultrasound to evaluate carpal tunnel syndrome before and after surgery. It may help doctors understand how the wrist changes after treatment.
São Paulo, São PauloAges 18 years+ - NCT07130773Recruiting
Comparing two catheter types for atrial fibrillation ablation
This trial compares two types of special catheters (thin tubes) used during a procedure called ablation to treat atrial fibrillation (irregular heartbeat). It aims to see which catheter works better during the procedure, and may help improve future treatments for people with heart rhythm problems.
Lugano, Canton TicinoAges 18 years+ - NCT07127926RecruitingPhase 1
Belumosudil pill vs crushed pill study for chronic GVHD
This trial tests whether crushing belumosudil tablets changes how the drug works in people with chronic graft-versus-host-disease (GVHD), a complication after a stem cell transplant. It helps doctors know if taking crushed pills is as effective as whole tablets.
Houston, TexasAges 18 years+ - NCT07131813RecruitingPhase 4
Tofacitinib for oral lichen planus
This trial tests whether adding the drug tofacitinib to standard treatment helps reduce symptoms of oral lichen planus, a chronic inflammatory mouth condition. It is for people with moderate to severe disease who have not taken certain immune-suppressing medicines recently.
Bhubaneswar, OdishaAges 18 years+ - NCT07127224Recruiting
Predicting recovery with smell tests in coma
This study tests whether a simple smell test can help predict recovery of consciousness in patients who remain in a coma or minimally conscious state after a severe brain injury. If you or your loved one has been unresponsive for several days after sedation is stopped, this trial may provide useful information about prognosis.
Paris, GHU Psychiatrie Et NeurosciencesAges 18 years+ - NCT07128979RecruitingPhase 4
Studying butcher’s broom for moderate hemorrhoids
This study tests a plant-based medication made from butcher’s broom (Ruscus aculeatus) to see if it safely helps people with moderate hemorrhoids. If you have stage II or III hemorrhoids and are between 18 and 45, you may be able to join.
IstanbulAges 18–45 - NCT07131267Recruiting
Study on sexual health in trans men during transition
This study aims to understand how sexual function changes for trans men as they go through the gender affirmation process. The results could help doctors provide better support for your sexual health during your transition.
Eskişehir, TürkiyeAges 18–65 - NCT07127757Recruiting
New laser vision correction study for nearsightedness
This study tests a newer version of LASIK eye surgery to correct nearsightedness and astigmatism. The researchers want to see if this laser approach is safe and effective for people who are eligible.
Greensboro, North CarolinaAges 18 years+ - NCT07135102RecruitingPhase 1
Radioactive drug for advanced prostate cancer
This study tests an experimental radioactive drug ([225Ac]Ac-PSMA-XT) that targets prostate cancer cells. It is for men whose prostate cancer has spread and stopped responding to standard hormone therapy and chemotherapy.
Jinan, ShandongAges 18 years+ - NCT07130487Recruiting
Cancer risk evaluation study for adults without cancer
This study tests a program to help people learn about their inherited cancer risk. It may be a good fit if you haven't had genetic testing or cancer before.
New Brunswick, New JerseyAges 18–70 - NCT07130968Enrolling by invitation
Heart and lung function study with exercise test and five-year follow-up
This study looks at how your heart and lungs work during exercise by using a special test called a cardiopulmonary exercise test (CPET). Researchers will follow you for up to five years to see how your health changes. It may help you understand your heart condition better and get more personalized care.
Guangzhou, GuangdongAges 18–80 - NCT07126236RecruitingPhase 2
Epcoritamab for first relapse of large B-cell lymphoma
This trial tests a new drug called epcoritamab for people whose large B-cell lymphoma has come back after or didn't fully respond to their first treatment. It's an option for those who cannot or choose not to have CAR-T therapy or a stem cell transplant.
Seville, AndalusiaAges 18 years+ - NCT07128472Recruiting
Genetic marker study in severe psoriasis with psoriatic arthritis
This study looks at a genetic marker (IL-12B) in people with severe psoriasis and psoriatic arthritis who are already on Humira. It may help understand why some people respond better to treatment.
QinaAges 18–70 - NCT07131007Recruiting
Early warning system for immunotherapy side effects
This study is for people with cancer who are already receiving immunotherapy (checkpoint inhibitors). It aims to build an early warning system to help detect and manage possible organ damage or other side effects from the treatment, using advanced testing to keep you safer.
Shijiazhuang, HebeiAges 18–80
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.